Medicale Corp.
MCLE
$0.45
-$0.02-4.26%
| Weiss Ratings | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 15.38% | |||
| 30-Day Total Return | 127.27% | |||
| 60-Day Total Return | 67.29% | |||
| 90-Day Total Return | 80.00% | |||
| Year to Date Total Return | 136.84% | |||
| 1-Year Total Return | 309.09% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -14.05% | |||
| 52-Week Low % Change | 886.36% | |||
| Price | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.55 | |||
| 52-Week Low Price | $0.05 | |||
| 52-Week Low Price (Date) | May 07, 2024 | |||
| 52-Week High Price (Date) | Mar 03, 2025 | |||
| Valuation | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.78M | |||
| Enterprise Value | 2.88M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | 8.64% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -24.87 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.45 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -61.98 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.92M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 407 245 7339 | |||
| Address | 9314 Forest Hill Blvd Wellington, FL 33411 | |||
| Website | www.medicalecorp.com | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -14,500.00% | |||
| Return on Equity | -- | |||
| Income Statement | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -46.40K | |||
| Net Income (TTM) | -51.70K | |||
| Net Income Avl. to Common (TTM) | -51.70K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 34.20% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 36.36% | |||
| Balance Sheet | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 200.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 200.00 | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -111.60K | |||
| Current Ratio (Q) | 0.011 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 200.00 | |||
| Total Current Liabilities (Q) | 18.20K | |||
| Total Debt (Q) | 93.60K | |||
| Total Liabilities (Q) | 111.80K | |||
| Total Common Equity (Q) | -111.60K | |||
| Cash Flow | MCLE - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 45.40K | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -26.10K | |||
| Cash from Operations (TTM) | -45.40K | |||
